View an earlier version
21 C.F.R. § 516.30
Cited by 1 regulation in release Current.
(1) Submission of annual progress reports in a timely manner in accordance with § 516.30 that demonstrate that the sponsor is progressing in accordance with the drug development plan submitted to the agency under § 516.20 and